LGA
FTXH icon

Lebenthal Global Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Lebenthal Global Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-625
Closed -$16K – 283
2020
Q4 		$16K Buy
+625
New +$15.6K 0.01% 400

Other funds holding FTXH

LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JAWM
J. Arnold Wealth Management Youngstown, Ohio $294M AUM 33.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return

Lebenthal Global Advisors's FTXH Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2021, closing a stake of 625 shares — an estimated $16K sold.

Lebenthal Global Advisors first reported a position in FTXH in Q4 2020 and held it in 1 quarter. The position peaked at $16K in Q4 2020. 19 funds tracked by Wall St. Rank hold FTXH as of Q1 2021.

  • Lebenthal Global Advisors reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
  • Lebenthal Global Advisors sold 625 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2021, an estimated $16K.
  • Lebenthal Global Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2020 and held it in 1 quarter.
  • Lebenthal Global Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $16K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.